U.S. flag

An official website of the United States government

NM_000243.3(MEFV):c.124C>T (p.Arg42Trp) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 11, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000780402.11

Allele description [Variation Report for NM_000243.3(MEFV):c.124C>T (p.Arg42Trp)]

NM_000243.3(MEFV):c.124C>T (p.Arg42Trp)

Gene:
MEFV:MEFV innate immunity regulator, pyrin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p13.3
Genomic location:
Preferred name:
NM_000243.3(MEFV):c.124C>T (p.Arg42Trp)
HGVS:
  • NC_000016.10:g.3256464G>A
  • NG_007871.1:g.5164C>T
  • NM_000243.3:c.124C>TMANE SELECT
  • NM_001198536.2:c.124C>T
  • NP_000234.1:p.Arg42Trp
  • NP_000234.1:p.Arg42Trp
  • NP_001185465.2:p.Arg42Trp
  • LRG_190t1:c.124C>T
  • LRG_190:g.5164C>T
  • LRG_190p1:p.Arg42Trp
  • NC_000016.9:g.3306464G>A
  • NM_000243.2:c.124C>T
  • O15553:p.Arg42Trp
Protein change:
R42W
Links:
UniProtKB: O15553#VAR_028326; dbSNP: rs61754767
NCBI 1000 Genomes Browser:
rs61754767
Molecular consequence:
  • NM_000243.3:c.124C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001198536.2:c.124C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000917624Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Aug 11, 2022)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The spectrum of Familial Mediterranean Fever (FMF) mutations.

Touitou I.

Eur J Hum Genet. 2001 Jul;9(7):473-83. Review.

PubMed [citation]
PMID:
11464238

Carrier testing for severe childhood recessive diseases by next-generation sequencing.

Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, Langley RJ, Zhang L, Lee CC, Schilkey FD, Sheth V, Woodward JE, Peckham HE, Schroth GP, Kim RW, Kingsmore SF.

Sci Transl Med. 2011 Jan 12;3(65):65ra4. doi: 10.1126/scitranslmed.3001756.

PubMed [citation]
PMID:
21228398
PMCID:
PMC3740116
See all PubMed Citations (8)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000917624.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

Variant summary: MEFV c.124C>T (p.Arg42Trp) results in a non-conservative amino acid change located in the DAPIN domain (also called pyrin domain (PYD), IPR004020) which is a protein-protein interaction domain involved in inflammasome assembly (Vajjhala_2014). Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0004 in 282866 control chromosomes, predominantly within the African or African-American subpopulation at a frequency of 0.004, including 1 homozygote in the gnomAD database. This frequency is not higher than expected for a pathogenic variant in MEFV causing Familial Mediterranean Fever (0.004 vs 0.022), allowing no conclusion about variant significance. c.124C>T has been reported in the literature in individuals affected with Familial Mediterranean Fever (FMF), however without strong evidence for pathogenicity (e.g. Moradian_2017). Therefore these data do not allow clear conclusions about variant significance. At least one publication reports experimental evidence on protein function, demonstrating an increased protein stability, possibly decreased auto-inhibition, but also a decreased protein-protein interaction (with ASC) that is important for the inflammasome assembly; the authors of this study hypothesized that the overall effects of the variant might contribute to FMF by facilitating activation of the pyrin inflammasome (Vajjhala_2014). Five other clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014, four classifying the variant as VUS and one as likely benign. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024